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Recently, evidence has been accumulated that besides the caspase proteases, lysosomal cathepsins may play a role in apoptosis
induction. This is especially significant as many human tumour cells express high levels of cathepsins, which might sensitise these cells
to specific proapoptotic stimuli mediated by cathepsins. We found that TNF-a-mediated DNA fragmentation in tumour cells was
significantly reduced in the presence of E64d and CA074Me, two inhibitors of lysosomal cysteine proteases. Transient transfection of
cathepsin-B (Cath-B) and -L (Cath-L) resulting in expression levels comparable to those found in many tumours did not sensitise
tumour cells to TNF-a-mediated apoptosis. As lysosomal proteases are thought to be activated by their release from this organelle
into the cytosol, we used the lysosomotropic detergent N-dodecyl-imidazole-HCl (NDI-HCl) to disturb lysosomal integrity efficiently
and trigger the release of its proteolytic content into the cytosol. Treatment of HeLa cells with NDI-HCl resulted in cell death, which,
however, could also not be influenced by augmented Cath-B or -L expression levels. Therefore, our data do not support the
hypothesis that the high Cath-B or -L expression levels frequently detected in tumour cells might be exploited to target selectively
those tumours for an enhanced cell death effect induced by lysosomotropic agents.
British Journal of Cancer (2003) 89, 1574–1580. doi:10.1038/sj.bjc.6601297 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: cell death; cathepsin; overexpression; lysosomes
                                         
The expression levels of the lysosomal papain-like cysteine
proteases cathepsin-B (Cath-B) and cathepsin-L (Cath-L) are
frequently strongly elevated in tumours of diverse origin. Their
secreted forms are thought to contribute to cancer progression and
metastasis either by directly degrading the extracellular matrix or
by proteolytically activating other extracellular proteases (Chau-
han et al, 1991; Duffy, 1996; Kos and Lah, 1998; Yan et al, 1998;
Sloane, 1990; Turk et al, 2000; Konduri et al, 2001). Therefore,
Cath-B and Cath-L are usually regarded as tumour markers
correlated with unfavourable clinical prognosis. On the other
hand, in recent years, evidence has been collected that lysosomal
proteases and particularly Cath-B might be involved in the
mediation of apoptotic cell death triggered by various stimuli.
This hypothesis has been built on observations that, firstly,
lysosomal integrity is disturbed during the apoptotic process with
concurrent release of the lysosomal content into the cytosol
(Guicciardi et al, 2000; Foghsgaard et al, 2001; Kagedal et al, 2001;
Mathiasen et al, 2001; Neuzil et al, 2002). Secondly, cathepsin
inhibitors can reduce the response of cells to some apoptosis
inducers (Foghsgaard et al, 2001; Kagedal et al, 2001; Katz et al,
2001; Kiso et al, 2001; Li et al, 2001; Mathiasen et al, 2001). Thirdly,
cells deficient or downregulated in Cath-B are more resistant to
TNF-mediated apoptosis (Guicciardi et al, 2000; Foghsgaard et al,
2001). Fourthly, in vitro cathepsins can trigger cytochrome c
release from the mitochondria into the cytosol (Guicciardi et al,
2000; Stoka et al, 2001). This and the fact that tumours
frequently contain high levels of cysteine proteases led to the
hypothesis that Cath-B-like proteases may prove useful in
selectively targeting tumour cells for apoptosis induction
(Foghsgaard et al, 2001).
In this report, we show that TNF-induced cell death in tumour
cells could be reduced in the presence of cysteine protease
inhibitors E64d and CA074Me, but that overexpression of Cath-B
and Cath-L comparable to the levels detected in tumour cells did
not increase the apoptosis sensitivity of those cells to TNF. Even
the proapoptotic effect of the lysosomotropic detergent N-dodecyl-
imidazole, which directly causes lysosomal instability, was not
affected by the intracellular content of Cath-B or Cath-L. Thus, our
data do not support the hypothesis that high levels of cathepsin
expression might result in the enhanced response of tumour cells
to proapoptotic stimuli.
MATERIALS AND METHODS
Materials
All fine chemicals were obtained from Sigma-Aldrich, unless
otherwise specified. TNF-a was obtained from Biomol, the pan-
caspase inhibitor zVAD-fmk was from Enzyme Systems Products,
E64d was from Biomol or Peptides International, CA074Me was
from Calbiochem or Peptides International, zFR-AMC was from
Enzyme Systems Products or Biomol, N-dodecyl-imidazole was
from Toronto Research Chemicals Inc., and its hydrochloride salt
was prepared essentially as given in Dubowchik et al (1995). Received 7 May 2003; revised 30 July 2003; accepted 5 August 2003
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HeLa cells and McA-RH7777 cells (kindly provided by Professor
Dr GM Kostner, Graz) were cultured in DME medium (Sigma)
supplemented with 2mML -glutamine, 1mM pyruvate, 100Uml
 1
penicillinþ100mgml
 1 streptomycin or 100mgml
 1 gentamycin
and 10% FCS. PC3 cells were kept in RPMI medium (Gibco)
containing the same supplements as described above for the DME
medium. Cells were incubated at 371Ca t5 %C O 2.
Constructs
Coding sequences of hCath-L (Accession M20496), hCath-B
(Accession L16510), and hCath-D (Accession M11233) were
obtained by RT–PCR from human cDNA and were cloned into
the pcDNA3D vector, which was derived from the pcDNA3 vector
(Invitrogen) by deletion of the neomycin resistance region. The
obtained cDNA sequences were sequenced and compared to the
above given Genbank sequence entries. For stable transfection
experiments, the corresponding constructs were subcloned into
the complete pcDNA3 vector containing the neomycin resistance
cassette.
Transfections
HeLa cells and McA RH 7777 cells were transfected using the
Effectene transfection reagent (Qiagen). For this, 0.2mg plasmid
DNA together with 50ng pEGFP (Clontech) were diluted in 100ml
of EC-Buffer, 1.6ml enhancer was added, and after 5min of
incubation at RT 2ml of the effectene transfection reagent was
added, followed by 15min of incubation at RT. The transfection
mix was given to HeLa cells in a six-well plate, which prior to that
had been washed with PBS and then 2ml of fresh DME medium
(10% FCS) had been added. The medium was changed 10h post-
transfection. This protocol could be up- and downscaled for
different culture formats. The transfection efficiency could be
controlled by fluorescence of the co-transfected pEGFP and was
determined by FACS analysis.
PI-FACS analysis
Apoptosis detection by sub-G1 DNA content was performed by
propidium iodide FACS analysis as described (Mund et al, 2003).
MTT assay
Cells were transfected in 10-cm dishes as described; 24h later cells
were harvested and reseeded in equal numbers (approximately
7500cells/well) in the wells of 96-well plates. At 24h after
reseeding, cells were treated as indicated in a total volume of
100ml DME medium. At the time of analysis, MTT assays were
essentially performed according to Mosmann (1983). ‘Loss of
viability, %’ was calculated using the following equation: (U S)/
U*100, where U is the absorption value of the untreated control
and S is the absorption value of sample.
Immunoblotting
For detecting protein expression, cells were harvested by
trypsinisation, washed with PBS, and lysed in Triton-X buffer
(50mM Tris-HCl pH 8.0, 150mM NaCl, 1% Triton-X 100) 10min on
ice. After centrifugation at 14000g in a microfuge, supernatants
were obtained as cytoplasmic extracts, which were quantified for
protein content using the Bradford reagent (BioRad). Western
blotting was performed as described (Bauer et al, 1999) using
either monoclonal anti-Cath-L antibody (Transduction Labora-
tories) or monoclonal anti-Cath-B antibody (Ab-2, Oncogene
Research Products).
Cathepsin enzymatic assay
Cells were left untreated or were transfected with the pcDNA3D
expression vector containing the ORFs of Cath-L, or Cath-B, and at
the time of analysis the cathepsin activity assay was performed
using zFR-AMC (Enzyme Systems Products) as a substrate,
applying a protocol derived from Kamboj et al (1993). AMC
fluorescence was measured with a Fluoroskan Ascent FL
fluorecence plate reader (Labsystems) at a wavelength of 380nm
for excitation and 450nm for emission. For measuring Michaelis–
Menten kinetics, the assay was performed as described above in
determining the initial turnover rates of the zFR-AMC substrate at
various concentrations (50, 100, 200, 400, and 600mM) in the
presence of 0.5mg protein extract from Cath-B overexpressing
HeLa cells.
Cell-free activation of caspases for inhibitor experiments
with E64d
Cytoplasmic extracts were prepared and activated by the addition
of cytochrome c and dATP in the absence or presence of various
concentrations of E64d, and were analysed by a caspase enzymatic
assay essentially as described (Gewies et al, 2000).
Immunocytochemistry
Cells were seeded on cover glasses, and 24h later were incubated
for 16h in the absence or presence of NDI-HCl, CHX, or TNF/
CHX. Immunostaining was carried out as described (Mathiasen
et al, 2001) using an anti-Cath-L mAb (1:100, Transduction
Laboratories) and an anti-mouse FITC-conjugated polyclonal Ab
(1:500, Pharmingen) as the primary or secondary antibody,
respectively. Fixed and stained cells were covered with an
embedding buffer (0.5 M Tris-HCl pH 8.2, 0.02gml
 1 DTT,
0.04gml
 1 polyvinyl alcohol, 40% glycerol), fluorescence was
observed under a fluorescence microscope (Axioscop 2, Zeiss), and
pictures were taken with a digital camera (Visitron Systems,
Puchheim) using the IPLab imaging software (Spectra Services,
NY, USA).
RESULTS
Cysteine protease inhibitors E64d and CA074Me suppress
TNF-mediated apoptosis
First, we asked whether lysosomal cysteine proteases might be
involved in apoptosis induced by TNF in the cervical carcinoma
cell line HeLa. Cell death was assessed by DNA fragmentation in
HeLa cells cotreated with TNF and cycloheximide (CHX). The pan-
caspase inhibitor zVAD-fmk could completely prevent the demise
of the cells, indicating an apoptotic mode of cell death (Figure 1A).
This cell death could also be inhibited in the presence of the broad-
spectrum cysteine protease inhibitor E64d in a dose-dependent
manner, albeit not as efficiently as with zVAD-fmk (Figure 1A).
We also used CA074Me, a described specific Cath-B inhibitor
(Buttle et al, 1992), and likewise detected a decrease of TNF-
induced DNA fragmentation (Figure 2B). Testing the prostatic
carcinoma cell line PC3 as a further cell system, we could confirm
the inhibitory effect of E64d, CA074Me, and zFA-FMK, a further
Cath-B inhibitor (Rasnick, 1985), on TNF-induced DNA fragmen-
tation (data not shown). To address the question of how general
the observed inhibitory effect of E64d on apoptotic DNA
fragmentation is, we tested its impact on UV-mediated cell death
in the HeLa cell system. As shown in Figure 1C, E64d did not
inhibit apoptosis induced by UV irradiation under the conditions
used.
The observation that the Cath-B inhibitor CA074Me is able to
reduce TNF-induced apoptosis in HeLa cells (Figure 1B) suggested
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we wanted to prove the specificity of CA074Me on Cath-B activity.
To this end, we transiently overexpressed hCath-B or hCath-L in
HeLa cells for subsequent inhibitor studies. Immunoblot analysis
demonstrated the efficient overexpression of these two cathepsins,
whereas endogenous levels of Cath-L and Cath-B in comparison
were quite low (Figure 2A). We also measured cathepsin activity in
extracts of Cath-B- or Cath-L-transfected cells, which were grown
for 3h in the presence or absence of 25mM E64d or 25mM
CA074Me, respectively. Concentrations in the range of 25mM had
been used in recent reports (Foghsgaard et al, 2001; Varghese et al,
2001) and were necessary to elicit an inhibitory effect (Figure 1).
As expected, E64d could strongly inhibit both hCath-L and hCath-
B enzymatic activity (Figure 2B). Unexpectedly, the supposedly
specific Cath-B inhibitor CA074Me not only inhibited the
enzymatic activity of the overexpressed hCath-B but also that of
the overexpressed hCath-L. However, this observation is in line
with a recent report (Montaser et al, 2002), which revealed that
before cleavage by cellular esterases the methyl ester CA074Me
cannot be regarded as a specific Cath-B inhibitor and also affects
other lysosomal cysteine proteases such as Cath-L. We also tested
the effect of E64d on caspase enzymatic activity in vitro: caspase
activity induced by the addition of cytochrome c and dATP to cell
extracts in a cell-free system was not significantly reduced in the
presence of 50mM E64d in the extract (data not shown), therefore
excluding the possibility that the effect of E64d on TNF-induced
apoptosis is due to the concurrent inhibition of caspases. Thus,
Cath-B and also related lysosomal cysteine proteases such as Cath-
L should be responsible for mediating the E64d- and CA074Me-
sensitive TNF signal.
As shown in Figure 2, the overexpression of hCath-B and hCath-
L could be obtained by transient transfection of HeLa cells in terms
of both protein levels detected in immunoblots (Figure 2A) as well
as cathepsin activities (Figure 2B). In these experiments, we
usually observed an increase of cathepsin activity by at least 6- to
10-fold for hCath-L or by 10- to 20-fold for hCath-B when
compared to endogenous cathepsin activity. This extent of
increased enzymatic activity is comparable to the situation found
in malignant human tumour cells for which elevated cathepsin-
expression and -activity levels have been described (Chauhan et al,
1991; Lah and Kos, 1998; Yan et al, 1998).
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Figure 1 Effect of cathepsin inhibitors on TNF- or UV-induced apoptosis
in HeLa cells. Cells were preincubated for 3h with the indicated amounts of
E64d or CA074Me and then cotreated with 10ngml
 1 TNF and 5mgml
 1
CHX (A, B) or irradiated with 40mJcm
 2 UV light (C). During treatment
or after irradiation, respectively, the cells were further kept in the presence
of the indicated concentrations of inhibitor and were analysed 12h (TNF)
or 20h (UV) later by propidium iodide FACS analysis. The values for every
data point were acquired in triplicate and are given as the percentage
(mean7s.d.) of apoptotic cells with sub-G1 chromosomal DNA content.
The data shown are representative for several independent experiments.
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Figure 2 Overexpression of hCath-L and hCath-B in HeLa cells and
inhibition of their enzymatic activity by E64d and CA074Me. Expression
vectors containing the cDNAs of human cathepsin-L (hCath-L) or human
cathepsin-B (hCath-B) were transfected into HeLa cells. (A) Cells were
harvested 24h post-transfection, and cell extracts were prepared and
analysed for the expression of hCath-L and hCath-B by immunoblot
analysis. (B) At 24h post-transfection, cells were incubated for 3h in the
absence or presence of the indicated inhibitor, harvested, and assayed for
cathepsin activity. The relative activity units (means7s.d.) were normalised
to the activity measured in nontransfected cells. Statistics are as described
in Figure 1.
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Cath-B induces apoptosis in HeLa cells
Given the possible involvement of Cath-B-like cysteine proteases
in TNF-mediated apoptosis in HeLa cells (Figure 1), we decided to
investigate the influence of cathepsin expression levels on the
sensitivity of HeLa cells to the TNF cell death signal. Especially,
Cath-B has been suggested to play an essential role in TNF-
mediated apoptosis (Leist and Jaattela, 2001), and has been
proposed to represent a therapeutical target in cancer therapy of
tumours with elevated levels of cysteine proteases (Foghsgaard
et al, 2001).
We first examined the effect of increased cathepsin expression
on the viability of HeLa cells (Figure 3). We observed cell death in
terms of morphology, DNA fragmentation, and caspase-3 enzy-
matic activity, when an hCath-D expression vector was transiently
transfected into HeLa cells (Figures 3A and B). The ectopic
overexpression of Cath-D in HeLa cells was previously shown to
induce cell death dominantly (Deiss et al, 1996). As an additional
positive control, we overexpressed the cysteine protease hUBP41, a
member of the family of ubiquitin-specific proteases (USPs), which
we recently found to possess dominant apoptosis-inducing activity
(Gewies and Grimm, 2003). In contrast, the overexpression of
hCath-L and hCath-B did not result in significant cell death, even
though in the case of hCath-L a slight increase in DNA
fragmentation values and caspase-3 activity could be detected
(Figures 3A and B), concomitant with an increased number of
detached cells (not shown). When we determined the cathepsin
activity, we observed an approximately 20-fold increase in these
experiments (Figure 3C).
Augmented levels of hCath-L or hCath-B fail to sensitise
HeLa or McA RH 7777 cells to TNF-induced cell death
With our results indicating that cathepsins participate in mediat-
ing TNF-induced apoptosis (Figure 1), we speculated that elevated
cathepsin expression levels might influence the sensitivity of HeLa
cells to the apoptosis-inducing signal triggered by TNF. As shown
in Figure 4A, HeLa cells transiently transfected with hCath-L or
hCath-B did not show any increased apoptosis when compared to
control transfected cells. We also generated HeLa cell pools stably
overexpressing hCath-L and hCath-B at levels of two- or four-fold
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Figure 3 Overexpression of hCath-D, but not of hCath-L or hCath-B
results in apoptosis induction in HeLa cells. HeLa cells were transfected
with hCath-L, hCath-B, hCath-D, or hUBP41 expression vectors together
with a pEGFP expression vector for the determination of transfection
efficiency. (A) At 48h post-transfection, cells were harvested for propidium
iodide FACS analysis for the detection of apoptotic cells with sub-G1 DNA
content. Transfection efficiency was included in the calculation of the
percentage of apoptosis. (B) At 32h post-transfection, the transfected cells
were harvested for the detection of caspase-3 activity and (C) for
verification of the overexpression of cathepsins by the zFR-AMC enzymatic
activity. Statistics are as given in Figure 1.
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Figure 4 Sensitivity to the TNF-mediated death signal is not enhanced
by overexpression of hCath-L or hCath-B. (A) HeLa cells were transfected
with pLuc, hCath-L, or hCath-B expression vectors, and 36h post-
transfection were incubated in the absence or presence of 5mgml
 1 CHX
or 10ngml
 1 TNF þ5mgml
 1 CHX. After 10h of treatment, cells were
harvested for propidium iodide FACS analysis. Transfection efficiency in this
experiment was 40% as determined by pEGFP cotransfection and EGFP
FACS analysis. (B) HeLa cell pools selected for stable expression of
pcDNA3, hCath-L, or hCath-B were incubated in the absence or presence
of 5mgml
 1 CHX or 10ngml
 1 TNFþ5mgml
 1 CHX. After 12h of
treatment, cells were harvested for propidium iodide FACS analysis. (C)
McA RH 7777 rat hepatoma cells were transiently transfected with pLuc,
hCath-L, or hCath-B expression vectors, and 36h post-transfection were
incubated in the absence or presence of 1mgml
 1 CHX, 10ngml
 1
TNFþ1mgml
 1 CHX, or 50ngml
 1 TNFþ1mgml
 1 CHX. After 12h of
treatment, cells were harvested for propidium iodide FACS analysis.
Transfection efficiency in this experiment was 40% as determined by
pEGFP cotransfection and EGFP FACS analysis. Statistics are as given in
Figure 1.
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those HeLa cells did not exhibit an enhanced response to TNF-
induced apoptosis (Figure 4B). Since Cath-B has been reported to
play a major role in the apoptosis of hepatocytes (Roberts et al,
1999; Guicciardi et al, 2000, ), we also transiently overexpressed
hCath-L or hCath-B in the rat hepatoma cell line McA RH 7777.
The treatment of these McA RH 7777 cells with TNF did not yield
any significant differences in apoptosis levels between control- and
cathepsin-transfected cells (Figure 4C).
The lysosomotropic detergent NDI-HCl causes cell death
that is not enhanced in HeLa cells overexpressing hCath-L
or hCath-B
The mode of action of lysosomal proteases for apoptosis is
assumed to involve the disintegration of lysosomes and the release
of their content into the cytosol. Subsequently, lysosomal proteases
cleave and activate proapoptotic factors such as the Bcl-2 family
member Bid, which leads to the release of cytochrome c from the
mitochondria and to the activation of caspases (Guicciardi et al,
2000; Turk et al, 2002). Consequently, we wanted to investigate
whether the integrity of lysosomes in TNF-treated HeLa cells is
disturbed so that elevated cathepsin levels within the lysosomes
caused by overexpression can be expected to result in higher
amounts of cathepsins in the cytosol. As a positive control, we
treated HeLa cells with the lysosomotropic detergent N-dodecyl-
imidazole hydrochloride (NDI-HCl), which accumulates in lyso-
somes and eventually damages the lysosomal membrane so that
the lysosomal content is released into the cytosol (Dubowchik et al,
1995). Anti-Cath-L immunofluorescent staining of untreated
control HeLa cells generated the expected spot-like lysosomal
distribution pattern of the endogenous Cath-L (Figure 5A). The
treatment of HeLa cells with TNF resulted in a considerable
number of cells with a decrease of staining intensity of discrete
lysosomal spots and an apparent partial redistribution of Cath-L
from those spot-like structures to a more evenly distributed
pattern as shown in Figure 5D. The application of NDI-HCl to
HeLa cells produced a uniform staining of Cath-L within still intact
cells, indicating extensive lysosomal rupture and release of its
content into the cytosol (Figure 5B).
We observed that incubation with NDI-HCl led to morpholo-
gical changes resembling apoptosis. Subsequent FACS analysis
confirmed apoptosis induced by NDI-HCl (not shown). We then
asked whether this cell death can be enhanced by overexpression
of hCath-L or hCath-B. For these measurements, we used the MTT
assay in order to also include nonapoptotic cell death. As shown in
Figure 6, expression levels of hCath-L or hCath-B did not have any
significant effect on NDI-HCl-induced cell death in HeLa cells as
determined by the MTT assays. Apoptosis quantification by FACS
analysis also did not reveal a differential cell death induction (not
shown). Cell death by NDI-HCl could be partially suppressed in
the presence of the pan-caspase inhibitor zVAD-fmk, indicating
caspase-dependent mechanisms. Interestingly, this type of cell
death could not be inhibited in the presence of the broad
specificity cysteine protease inhibitor E64d (Figure 6).
DISCUSSION
Caspases are thought to build the central proteolytic network
involved in the execution of apoptotic signalling pathways induced
by virtually all kinds of death stimuli (Earnshaw et al, 1999;
Nagata, 1999; Robertson and Orrenius, 2000). In recent years, it
has been recognised that besides caspases other proteases such as
cathepsins, calpains, and the proteasome also may play a role as
cofactors in mediating several cell death stimuli, for example,
Cath-B in TNF-induced apoptosis (Leist and Jaattela, 2001). Cath-B
has been reported to be released from the lysosomes to the cytosol
in response to TNF (Guicciardi et al, 2000; Foghsgaard et al, 2001)
and to contribute to apoptotic downstream events such as
cytochrome c release and the activation of executioner caspases
(Guicciardi et al, 2000; Stoka et al, 2001). These observations
suggest a possible role for cathepsins as positive effectors of cell
death pathways. This and the fact that tumours frequently contain
high levels of cysteine proteases led to the hypothesis that Cath-B-
like proteases may prove useful in selectively targeting tumour
cells for apoptosis induction (Foghsgaard et al, 2001). The central
objective of this study was to test the hypothesis of whether
increased expression levels of Cath-L or Cath-B would enhance the
sensitivity of tumour cells to TNF-mediated apoptosis. We found
this not to be the case, even though inhibitor studies provided
evidence for an influence of cathepsins in the TNF signalling
pathway: apoptotic DNA fragmentation induced by cotreatment of
HeLa and PC3 cells with TNF and CHX could be significantly
suppressed by the cathepsin inhibitors E64d and CA074Me in a
dose-dependent manner (Figures 1A and B), which is in line with
previous reports (Guicciardi et al, 2000; Foghsgaard et al, 2001).
Interestingly, apoptosis induced by irradiating the cells with UV
light could not be diminished in the presence of E64d (Figure 1C).
Thus, in HeLa cells, cathepsins appear to contribute to the
extrinsic receptor-mediated TNF cell death pathway, but not to the
intrinsic apoptosis signalling pathways induced by UV.
The inhibitor CA074Me is usually regarded to be highly selective
for Cath-B, and thus one could conclude that Cath-B is the
noncaspase cysteine protease contributing to TNF-mediated
apoptosis in the HeLa cell system. When we tried to verify the
specific inhibitory activity of CA074Me, we realised that CA074Me
not only completely blocked hCath-B enzymatic activity but also
blocked hCath-L activity to almost the same extent (Figure 2B).
A
B
C
D
Control
NDI-HCl
CHX
TNF + 
CHX
Figure 5 Immunostaining against endogenous Cath-L in HeLa cells
treated with TNF/CHX or the lysosomotropic detergent NDI-HCl. HeLa
cells were cultivated for 16h in the absence (A) or presence of 100mM
NDI-HCl (B), 2mgml
 1 CHX (C), or 10ngml
 1 TNFþ2mgml
 1 CHX
(D) and were then fixed and immunostained using an anti-Cath-L mAb and
an FITC-labelled anti-mouse mAb. Cells were microscopically inspected
under a UV lamp and images were taken using a digital imaging system.
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demonstrating that CA074Me is not a selective inhibitor of Cath-B
(Montaser et al, 2002). Therefore, we cannot rule out the fact that
besides Cath-B, CA074Me also inhibits other cysteine proteases
such as Cath-L, and by this exerts its inhibitory effect.
There are several reports about strongly augmented expression
levels of Cath-L and Cath-B detected in tumour cells. Frequently,
the increase in cathepsin expression and activity correlated with
malignant progression and metastasis possibly by direct degrada-
tion of the extracellular matrix or by activation of other proteases
such as the urokinase-type plasminogen activator (Turk et al,
2000). Consequently, cathepsins are regarded to be tumour
markers with their increased expression levels correlating with
poor prognosis (Yan et al, 1998; Sloane, 1990; Chauhan et al, 1991;
Sivaparvathi et al, 1995; Duffy, 1996; Lah and Kos, 1998). The
tumour-promoting effect of cathepsins is in contrast to the
observation that cathepsins such as Cath-B can mediate proapop-
totic signals triggered by TNF (Foghsgaard et al, 2001; Guicciardi
et al, 2001; Mathiasen et al, 2001), bile salts (Roberts et al, 1999),
sphingosine (Kagedal et al, 2001), activation of the B-cell receptor
(Katz et al, 2001), and L-2,5-dihydrophenylalanine (Kiso et al,
2001). Consequently, we wanted to address the question of whether
this contrast might prove useful in developing a cancer therapy
selectively targeting tumour cells for cell death, which express high
levels of cathepsins (Foghsgaard et al, 2001). Even though this
concept appears attractive, up to now no studies have been
presented investigating a possible correlation between elevated
cellular cathepsin levels and sensitivity to apoptotic stimuli. Since
our inhibitor studies indicated a contribution of Cath-B-like
cysteine proteases in TNF-induced apoptosis in HeLa cells
(Figure 1), we decided to investigate whether the sensitivity of
HeLa cells to the TNF signal is enhanced by increased levels of
hCath-L or hCath-B. We found that the overexpression of hCath-L
or hCath-B by itself does not result in overt apoptosis induction in
HeLa cells, whereas overexpression of hCath-D led to apoptosis as
could be expected from a previous report (Deiss et al, 1996). In
these transient transfection experiments, we usually obtained
between 40 and 60% transfection efficiency as judged by GFP
cotransfection and an increase of cathepsin activity of at least 6- to
10-fold for hCath-L and 10- to 20-fold in case of hCath-B.
This is comparable to the activities frequently detected in tumour
tissues (Chauhan et al, 1991; Lah and Kos, 1998; Yan et al,
1998).
Consequently, under these experimental conditions we expected
to be able to uncover any increase in sensitivity correlated with
cathepsin overexpression. However, we did not detect a significant
increase in sensitivity to TNF-induced apoptosis in HeLa cells
transiently transfected with hCath-L or hCath-B (Figure 4A).
Secondly, we generated HeLa cell pools stably overexpressing
hCath-L or hCath-B, respectively. In this case, we could assume
that the majority of cells express the corresponding cathepsin,
although at a lower level than in transient expression experiments.
Those stable transfected pool clones also did not show any
augmented sensitivity to the TNF death signal (Figure 4B). Thirdly,
we used the rat hepatoma cell line McA RH 7777 for transient
expression experiments, which also did not indicate any change in
sensitivity to TNF upon cathepsin overexpression (Figure 5C). We
chose this additional cell line since hepatocytes have been
described to be influenced by the proapoptotic activity of Cath-B
(Roberts et al, 1999; Guicciardi et al, 2000, 2001).
The release of lysosomal cathepsins into the cytosol is thought to
be decisive for their apoptosis induction. As shown in Figure 5,
lysosomal integrity is apparently disturbed when HeLa cells are
treated with TNF-a, as indicated by the partial redistribution of
endogenous Cath-L from a lysosomal spot-like pattern to a more
diffuse staining. Thus, increased expression levels of cathepsins
should also be expected to result in higher amounts of cathepsin
activity in the cytoplasm in response to TNF. How can it then be
explained that we observe an inhibitory effect of TNF-induced
apoptosis by the cathepsin inhibitors E64d and CA074Me
(Figure 1), but do not see any effect upon cathepsin overexpression
(Figures 4 and 5)? Firstly, it cannot be excluded that cathepsin-like
proteases other than Cath-L or Cath-B are mainly responsible for
the contribution to TNF-a apoptotic pathways, since the inhibitors
E64d and apparently also CA074Me are not specific inhibitors of
distinct cathepsins (Figure 2; Montaser et al 2002). Secondly, it is
also possible that the endgenous basal levels of lysosomal Cath-L
or Cath-B activity are sufficient to provide the lysosomal stimulus
contributing to the proapoptotic signalling cascade for cell death
execution. In this case, downstream or upstream factors other than
Cath-L or Cath-B levels could be rate limiting in the execution
process of apoptosis, and an increase in Cath-L or Cath-B levels
would not further accelerate or enhance the signal from the TNF
receptor. Supporting this, we obtained the linear relationship of a
Lineweaver–Burke plot using overexpressed Cath-B and the test
substrate zFR-AMC (data not shown). This indicates that cathepsin
proteolysis obeys the Michaelis–Menten kinetics. Consequently,
an x-fold increase in Cath-B levels corresponds to an x-fold
increase of substrate turnover. Therefore, overexpression of Cath-
B in our transfection experiments should correlate with an
increased turnover of endogeneous Cath-B substrates.
Both possible explanations described above could be valid and
would be in line with our observation that overexpression of
hCath-L or hCath-B does not show any death-enhancing effect in
NDI-HCl-induced cell death (Figure 6), even though it can be
assumed in this case that treatment with NDI-HCl efficiently
released the overexpressed cathepsins from the lysosomal com-
partments to the cytosol (Figure 5). We must point out that NDI-
HCl-induced death behaves differently from TNF-mediated
apoptosis, since NDI-HCl results in cell death that cannot be
reduced by E64d, and zVAD-fmk can only partially block cell death
(Figure 6), presumably due to the extreme extent of lysosomal
rupture caused by this lysosomotropic detergent (Figure 5B)
leading to both a caspase-dependent apoptotic mode and a
caspase-independent mode of cell death.
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Figure 6 Cell death induced by NDI-HCl is not enhanced by
overexpression of hCath-L or hCath-B. HeLa cells were transfected with
pLuc, hCath-L, or hCath-B expression vectors; 24h later, equal cell
numbers were reseeded in wells of a 96-well plate and again 24h later
were incubated in the absence or presence of the indicated amounts of
NDI-HCl in the absence or presence of either 50mM zVAD-fmk or 50mM
E64d. After 22h of treatment, cells were analysed by MTT assay as
described in Materials and Methods. Transfection efficiency was determined
by pEGFP cotransfection and was 450%. The data shown are the means
of four independent experiments in which each data point was measured in
hexaplicate.
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sIn conclusion, Cath-B-like cysteine proteases seem to contribute
to certain aspects of apoptotic signalling pathways that involve the
disruption of lysosomes. Whereas the possibility appeared
attractive to exploit the release of cathepsins in specifically
targeting tumour cells with elevated cathepsin expression levels
for cell death induction, our overexpression experiments do not
support this hypothesis. This is, to our knowledge, the first report
directly investigating a possible correlation between cathepsin
expression levels and the sensitivity to an apoptotic stimulus, and
further studies could extend these findings to other cell systems
and additional cell death stimuli.
ACKNOWLEDGEMENTS
A.G. was supported by the SFB 469. This work was supported
by Bavarian Government, Roche Diagnostics, and Xantos
Biomedicine AG.
REFERENCES
Bauer MK, Schubert A, Rocks O, Grimm S (1999) Adenine nucleotide
translocase-1, a component of the permeability transition pore, can
dominantly induce apoptosis. J Cell Biol 147: 1493–1502
Buttle DJ, Murata M, Knight CG, Barrett AJ (1992) CA074 methyl ester: a
proinhibitor for intracellular cathepsin B. Arch Biochem Biophys 299:
377–380
Chauhan SS, Goldstein LJ, Gottesman MM (1991) Expression of cathepsin L
in human tumors. Cancer Res 51: 1478–1481
Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A (1996) Cathepsin D
protease mediates programmed cell death induced by interferon-gamma,
Fas/APO-1 and TNF-alpha. Embo J 15: 3861–3870
Dubowchik GM, Gawlak SL, Firestone RA (1995) The in vitro effects of
three lysosomotropic detergents against three human tumor cell lines.
Bioorganic Med Chem Lett 5: 893–898
Duffy MJ (1996) Proteases as prognostic markers in cancer. Clin Cancer Res
2: 613–618
Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases:
structure, activation, substrates, and functions during apoptosis. Annu
Rev Biochem 68: 383–424
Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M,
Elling F, Leist M, Jaattela M (2001) Cathepsin B acts as a dominant
execution protease in tumor cell apoptosis induced by tumor necrosis
factor. J Cell Biol 153: 999–1010
Gewies A, Grimm S (2003) UBP41 is a proapoptotic ubiquitin-specific
protease. Cancer Res 63: 682–688
Gewies A, Rokhlin OW, Cohen MB (2000) Cytochrome c is involved in Fas-
mediated apoptosis of prostatic carcinoma cell lines. Cancer Res 60:
2163–2168
Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C,
Kaufmann SH, Gores GJ (2000) Cathepsin B contributes to TNF-alpha-
mediated hepatocyte apoptosis by promoting mitochondrial release of
cytochrome c. J Clin Invest 106: 1127–1137
Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ (2001) Cathepsin B
knockout mice are resistant to tumor necrosis factor-alpha-mediated
hepatocyte apoptosis and liver injury: implications for therapeutic
applications. Am J Pathol 159: 2045–2054
Kagedal K, Zhao M, Svensson I, Brunk UT (2001) Sphingosine-induced
apoptosis is dependent on lysosomal proteases. Biochem J 359:
335–343
Kamboj RC, Pal S, Raghav N, Singh H (1993) A selective colorimetric assay
for cathepsin L using Z-Phe-Arg-4-methoxy-beta-naphthylamide.
Biochimie 75: 873–878
Katz E, Deehan MR, Seatter S, Lord C, Sturrock RD, Harnett MM (2001) B
cell receptor-stimulated mitochondrial phospholipase A2 activation
and resultant disruption of mitochondrial membrane potential correlate
with the induction of apoptosis in WEHI-231 B cells. J Immunol 166:
137–147
Kiso T, Usuki Y, Ping X, Fujita K, Taniguchi M (2001) L-2,5-dihydro-
phenylalanine, an inducer of cathepsin-dependent apoptosis in
human promyelocytic leukemia cells (HL-60). J Antibiot (Tokyo) 54:
810–817
Konduri S, Lakka SS, Tasiou A, Yanamandra N, Gondi CS, Dinh DH,
Olivero WC, Gujrati M, Rao JS (2001) Elevated levels of cathepsin B in
human glioblastoma cell lines. Int J Oncol 19: 519–524
Kos J, Lah TT (1998) Cysteine proteinases and their endogenous inhibitors:
target proteins for prognosis, diagnosis and therapy in cancer (review).
Oncol Rep 5: 1349–1361
Lah TT, Kos J (1998) Cysteine proteinases in cancer progression and their
clinical relevance for prognosis. Biol Chem 379: 125–130
Leist M, Jaattela M (2001) Triggering of apoptosis by cathepsins. Cell Death
Differ 8: 324–326
Li W, Dalen H, Eaton JW, Yuan XM (2001) Apoptotic death of
inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol
21: 1124–1130
Mathiasen IS, Hansen CM, Foghsgaard L, Jaattela M (2001) Sensitization to
TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-
regulation of the TNF receptor 1 and cathepsin B. Int J Cancer 93:
224–231
Montaser M, Lalmanach G, Mach L (2002) CA-074, but not its methyl ester
CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol
Chem 383: 1305–1308
Mosmann T (1983) Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays. J Immunol
Methods 65: 55–63
Mund T, , Gewies A, , Schoenfeld N, Bauer MKA, Grimm S (2003) Spike, a
novel BH3-only protein, regulates apoptosis at the endoplasmic
reticulum. FASEB J 17: 696–698
Nagata S (1999) Fas ligand-induced apoptosis. Annu Rev Genet 33: 29–55
Neuzil J, Zhao M, Ostermann G, Sticha M, Gellert N, Weber C, Eaton JW,
Brunk UT (2002) Alpha-tocopheryl succinate, an agent with in vivo anti-
tumour activity, induces apoptosis by causing lysosomal instability.
Biochem J 362: 709–715
Rasnick D (1985) Synthesis of peptide fluoromethyl ketones and the
inhibition of human cathepsin B. Anal Biochem 149: 461–465
Roberts LR, Adjei PN, Gores GJ (1999) Cathepsins as effector proteases in
hepatocyte apoptosis. Cell Biochem Biophys 30: 71–88
Robertson JD, Orrenius S (2000) Molecular mechanisms of apoptosis
induced by cytotoxic chemicals. Crit Rev Toxicol 30: 609–627
Sivaparvathi M, Sawaya R, Wang SW, Rayford A, Yamamoto M, Liotta LA,
Nicolson GL, Rao JS (1995) Overexpression and localization of cathepsin
B during the progression of human gliomas. Clin Exp Metastasis 13: 49–56
Sloane BF (1990) Cathepsin B and cystatins: evidence for a role in cancer
progression. Semin Cancer Biol 1: 137–152
Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM,
Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC,
Yin XM, Turk V, Salvesen GS (2001) Lysosomal protease pathways to
apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J
Biol Chem 276: 3149–3157
Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic
K, Turk V (2002) Apoptotic pathways: involvement of lysosomal
proteases. Biol Chem 383: 1035–1044
Turk B, Turk D, Turk V (2000) Lysosomal cysteine proteases: more than
scavengers. Biochim Biophys Acta 1477: 98–111
Varghese J, Radhika G, Sarin A (2001) The role of calpain in caspase
activation during etoposide induced apoptosis in T cells. Eur J Immunol
31: 2035–2041
Yan S, Sameni M, Sloane BF (1998) Cathepsin B and human tumor
progression. Biol Chem 379: 113–123
Cathepsin overexpression and sensitivity to TNFa
A Gewies and S Grimm
1580
British Journal of Cancer (2003) 89(8), 1574–1580 & 2003 Cancer Research UK
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s